Monitoring the manufacture and marketing of medical devices will become part of the National Supervisory Authority for Welfare and Health, i.e. Valvira, as of 1 November 2009.
Valvira was established as a result of the merger of the National Product Control Agency for Welfare and Health (STTV) and the National Authority for Medicolegal Affairs (TEO) on 1 January 2009. Valvira (www.valvira.fi) shall improve the management of health risks in the environment as well as legal protection and the quality of services in social welfare and health care.
As reported in the previous Life Sciences Update, the Finnish Medicines Agency (“Fimea”), a new state authority for medicines in Finland, will start running its operations on 1 November 2009 as well. In connection with the establishment of Fimea, the Finnish National Agency for Medicines (the “NAM”) will be abolished and the activities will be transferred from the capital Helsinki to the city of Kuopio located about 400 kilometers from Helsinki.
Fimea will handle the present tasks of the NAM associated with authorisation and supervision of medicinal products. However, as part of the reorganisation of the administration of health care and social welfare in Finland, the functions of the Medical Devices Department of the NAM will be transferred to Valvira.